Scn5atm1Pec
Targeted Allele Detail
|
Symbol: |
Scn5atm1Pec |
Name: |
sodium channel, voltage-gated, type V, alpha; targeted mutation 1, Peter Carmeliet |
MGI ID: |
MGI:2388158 |
Synonyms: |
deltaKPQ-SCN5A, Scn5adelta |
Gene: |
Scn5a Location: Chr9:119312474-119408082 bp, - strand Genetic Position: Chr9, 71.33 cM
|
Alliance: |
Scn5atm1Pec page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:71542
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted |
Mutation: |
|
Intragenic deletion
|
|
|
Mutation details: Sequence encoding lyusine-proline-glutamine (residues 1505-1507) were replaced by a single loxP site via homologous recombination followed by in vitro cre mediated excision. This deletion was designed to emulate long-QT3 (LQT3) syndrome, which results in the prolongation of the electrocardiographic QT interval. Quantitative RT-PCR and Western blot analysis confirmed that both transcript and protein levels produced by the targeted allele were comparable to wild-type expression.
(J:71542)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Scn5a Mutation: |
105 strains or lines available
|
|
Original: |
J:71542 Nuyens D, et al., Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med. 2001 Sep;7(9):1021-7 |
All: |
10 reference(s) |
|